EP0996380A1 - Elektrochirurgische vorrichtung und verfahren zum abdichten von gewebe - Google Patents

Elektrochirurgische vorrichtung und verfahren zum abdichten von gewebe

Info

Publication number
EP0996380A1
EP0996380A1 EP98935803A EP98935803A EP0996380A1 EP 0996380 A1 EP0996380 A1 EP 0996380A1 EP 98935803 A EP98935803 A EP 98935803A EP 98935803 A EP98935803 A EP 98935803A EP 0996380 A1 EP0996380 A1 EP 0996380A1
Authority
EP
European Patent Office
Prior art keywords
tissue
solution
jaw portions
sealing
electrical energy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP98935803A
Other languages
English (en)
French (fr)
Other versions
EP0996380B1 (de
Inventor
Peter M. J. Mulier
Michael F. Hoey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of EP0996380A1 publication Critical patent/EP0996380A1/de
Application granted granted Critical
Publication of EP0996380B1 publication Critical patent/EP0996380B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1442Probes having pivoting end effectors, e.g. forceps
    • A61B18/1445Probes having pivoting end effectors, e.g. forceps at the distal end of a shaft, e.g. forceps or scissors at the end of a rigid rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1425Needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1472Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2218/00Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2218/001Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
    • A61B2218/002Irrigation

Definitions

  • This invention relates to medical instruments, and more particularly to electrosurgical devices, and methods of manipulating tissue as, for example, by cutting the tissue.
  • High-frequency alternating current was used to cut and coagulate human tissue as early as 1911.
  • Current generators and electrode tipped instruments then progressed such that electrosurgical instruments and current generators are available in a multitude of configurations for both open procedures and endoscopic procedures, with microprocessor-controlled currents typically on the order of 500KHz.
  • Radiofrequency (RF) catheter ablation of brain lesions began in the 1960s, and RF ablation of heart tissue to control supraventricular tachyarrhythmias began in the 1980s.
  • electrical energy including but not limited to RF energy
  • RF energy is a known tool for a variety of effects on human tissue, including cutting, coagulating, and ablative necrosis, with and as a part of electrically conductive forceps.
  • Bipolar and monopolar currents are both used with electrosurgical forceps. With monopolar current, a grounding pad is placed under the patient.
  • a recent example of an electrically energized electrosurgical device is disclosed in U.S. Patent No. 5,403,312 issued on April 4, 1995 to Yates et al., and the disclosure is incorporated by reference.
  • An object of the present invention is to provide an electrosurgery tissue sealing medical device which may and also may not be a forceps.
  • Another object of the present invention is to provide an electrosurgery tissue sealing device such as a forceps that seals tissue by a unique flow of an electrolytic fluid or solution to the manipulating portions of the device in combination with energization of the solution with electrical energy.
  • the effect of the solution and energy may be enhanced with pressure.
  • the solution is brought into contact with and infuses the tissue.
  • the solution may include saline as well as other non-toxic and toxic electrolytic solutions, and may be energized with RF electrical energy.
  • the body of the device itself may or not be energized.
  • the solution provides at least in part the beneficial functions and effects of the instrument.
  • pressure on the tissue is applied, and most preferably the effect of pressure is optimized, as by applying pressure across the tissue to be effected that is substantially uniform.
  • Another object of the invention is to provide an electrosurgery medical device as described, and methods of sealing tissue, in which tissues are sealed against flow of fluids including air.
  • lung tissue is aerostatically and hemostatically sealed, with the tissue adjacent the sealed tissue retaining blood and air.
  • Another object of the invention is to provide an electrosurgery medical device that may take the form of open surgery forceps of a variety of specific forms, or endoscopic forceps, also of a variety of forms.
  • a further object of the invention is to provide an electrosurgery medical device as described, in which the electrolytic solution by which the instrument functions is infused from the device onto and/or into the tissue along the operative portions of the device. With and without applied pressure, the solution coagulates and additionally seals tissue, as a result of being energized by RF energy, and also envelopes the operative portions of the device in solution all during manipulation of tissue, substantially completely preventing adherence between the instrument and tissue, substantially without flushing action.
  • the invention takes the form of an enhanced solution-assisted electrosurgery medical device comprising, in combination, cooperating device jaws including jaw portions for manipulating tissue, and a plurality of solution infusion openings defined and spaced along each of the jaw portions, for receiving solution and infusing solution onto and into the tissue along said jaw portions.
  • the device is contemplated with and without grooves, as preferred, the device further comprises at least one, and most preferably, many, longitudinal grooves along at least one and most preferably, both, of the jaw portions.
  • the solution infusion openings are located on the inside faces of the jaw portions, adjacent to and most preferably in the groove or grooves. The solution exiting the openings separates substantially all the operative surfaces of the device from tissue, substantially completely preventing adherence between the operative surfaces and tissue. The solution also aids in coagulation.
  • the invention causes hemostasis, aerostasis, and more generally, Aomnistasis@ of substantially any and all liquids and gases found in tissue being treated, such as lymphatic fluids and methane, as well as blood and air.
  • tissue being treated such as lymphatic fluids and methane
  • the operative portions of the device may take the form of a circular, semicircular or other regular and irregular geometric shape, to contain and/or isolate tissue to be affected and perhaps resected.
  • tissue surrounding lesions and/or tumors of the lung may be aerostatically and hemostatically sealed, resulting in an isolation of the lesions and/or tumors for resection. Lung function is retained.
  • the operative portions of the device may be malleable, to be manipulated to substantially any needed contour.
  • the device may include an advanceable and retractable blade, or additional functional structures and features.
  • Fig. 1 is a schematic diagram of the key elements of an electrical circuit according to the invention.
  • Fig. 2 is a perspective view of an endoscopic forceps according to the invention.
  • Fig. 3 is a detail view of a portion of the forceps of Fig. 2;
  • Fig. 4 is a perspective view of a modification of the embodiment of Fig. 2;
  • Fig. 5 is a second modification, of the embodiment of Fig. 4, shown partially broken away;
  • Fig. 6 is a perspective view of an open surgery forceps according to the invention.
  • Fig. 7 is a detail view of a portion of the forceps of Fig. 6, partially broken away;
  • Fig. 8 is a schematic view of preferred saline supply equipment for the invention.
  • Fig. 9 is a perspective view of a portion of the jaws of an alternative device.
  • Fig. 10 is a perspective view similar to Fig. 9 of another alternative device.
  • Fig. 11 is a cross-sectional view along line 11-11 of Fig. 9;
  • Fig. 12 is a perspective view of yet another alternative device. DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Electrosurgery uses electrical energy to heat tissue and cause a variety of effects such as cutting, coagulation and ablative necrosis.
  • the heat arises as the energy dissipates in the resistance of the tissue.
  • the effect is dependent on both temperature and time. Lower temperatures for longer times often yield the same effect as higher temperatures for shorter times.
  • Normal body temperature is approximately 37°C. No significant long-term effect is caused by temperatures in the range of 37°C to 40°C. In the range of 41°C to 44°C, cell damage is reversible for exposure times less than several hours. In the range of 45°C to 49°C, cell damage becomes irreversible at increasingly short intervals.
  • Asoft@ coagulation occurs at temperatures slightly above 70°C. Heat denatures and shrinks tissues and blood vessels, thereby leading, as desired, to control of bleeding. Cells are generally not ruptured. ASoft@ coagulation is generally assured with voltages below 200 peak Volts. Sparks are avoided. AForced® coagulation can be accomplished with bursts of electrical energy. Electric arcs are generated. Deeper coagulation is achieved, at the cost of some carbonization and an occasional cutting effect. Spray coagulation is also possible. Tissue cutting occurs by desiccation, when the concentration of electrical energy, also referred to here as energy density, is acute, and the temperature of tissue is raised above 100°C.
  • a sine wave waveform is employed, with a frequency of about 500 kHz.
  • increasing voltage to as much as 600 peak Volts leads to higher spark intensity which results in deeper cuts.
  • Frequencies above 300,000 Hz avoid stimulating nerve and muscle cells, and generally assure that the effect on tissue is substantially purely thermal.
  • significant purposes of the present invention are to provide a mechanism of avoiding desiccation of tissue at the electrode/tissue interface and to achieve sealing of tissues.
  • Asealing,® the effects of hemostasis, or arresting of bleeding;
  • Aaerostasis,@ or arresting of the passage of air; and closure of tissues such as blood vessels against larger-scale passage of blood, among other effects, are intended. More specifically, the effect of sealing at the cellular level is a primary focus, as is sealing at the vascular level.
  • key elements of a preferred electrical circuit according to the invention include an electrosurgical unit 10, a switch 12, and electrodes 14, 16. An effect is created on tissue 18 of a body 20.
  • One electrode such as electrode 14 acts as a positive or active electrode, while the other such as electrode 16 acts as a negative or return electrode. Current flows directly from one electrode to the other primarily through only the tissue, as shown by arrows 22, 24, 26, 28, 29. No pad is needed under the patient. This is a bipolar configuration.
  • a forceps 30 is an endoscopic forceps, and includes manual handles 32, 34, an elongated shaft 36, and jaws 38, 40.
  • the handles 32, 34 pivot together and apart and through a suitable mechanism (not shown; present in the incorporated prior art) control the jaws 38, 40 to also pivot together and apart about a pivot connection 42.
  • each jaw 38, 40 is formed in two parts, hinged together.
  • the jaw 38 includes a link portion 44 connected directly to the forceps shaft 36, and the jaw 40 includes a link portion 46 also connected directly to the forceps shaft 36.
  • a jaw portion 48 hingedly fastened to the jaw link portion 44 completes the jaw 38; a jaw portion 50 hingedly fastened to the jaw link portion 46 completes the jaw 40.
  • a solution supply tube 52 supplies electrolytic solution to an electrode strip 47 along the jaw portion 48, as will be described.
  • a solution supply tube 54 supplies electrolytic solution to a similar strip 49 along the jaw portion 50.
  • a wire 56 electrically connects to the solution supply tube 52; a wire 58 electrically connects to the solution supply tube 54. All the supplies 52, 54, 56, 58, both solution and electrical, extend from the proximal or manual handle end of the shaft 36, and connect to solution and electrical sources.
  • a jaw portion 150 similar to jaw portion 50 in Fig. 3 includes a longitudinal dimension in the direction of arrow 160.
  • a plurality of longitudinal grooves 162 are spaced side- by-side across the inner face 164 of the jaw portion 150.
  • the grooves 162 extend the full longitudinal length of the jaw portion 150.
  • Both jaw portions are incorporated in a structure as in Fig. 3, and could be placed in substitution for jaw portions 48, 50 in Fig. 3.
  • Grooves also preferably extend along the corresponding jaw portions 48, 50 of Figs. 2-3. Orientations of the grooves other than longitudinal are considered possible, within the limit of construction and arrangement to substantially retain solution along the operative jaw portions.
  • Bodily tissues to be manipulated have a natural surface roughness. This roughness significantly reduces the area of contact between the forceps jaws and manipulated tissues. Air gaps are created between conventional smooth-surfaced jaws and tissues. If the jaws were energized when dry, electrical resistance in the tissues would be increased, and the current density and tissue temperature would be extremely high. In practice, tissue surfaces are sometimes wet in spots, and yet tissue wetness is not controlled, such that electrical power is to be set on the assumption the inner jaw surfaces are dry. This assumption is necessary to minimize unwanted arcing, charring and smoke.
  • the jaw portions are uniquely formed of a material such as hollow stainless steel needle tubing such that solution infusion openings 166 may be and are formed in the jaw inner faces such as the inner face 164, as in Fig. 4.
  • the solution supplies 52, 54 shown by example in Fig. 3 may and do open into the openings 166, to supply solution to the openings 166.
  • the openings 166 are laser drilled, and have a diameter in a range centered around four thousandths
  • the purpose of the openings 166 is to infuse solution onto and/or into the tissue adjacent to and otherwise in contact with the forceps jaw portions inner surfaces. It is understood the openings are appropriately as small in diameter as described above to assure more even flow among the openings than would otherwise occur. Further, the openings need not be so closely spaced as to mimic the surface roughness as tissues. Microporous surfaces are possibly acceptable, while they are also not necessary. Infusion of fluid through the jaws is to be maintained in a continuous flow during and throughout the application of RF energy in order for the desired tissue effect to be achieved. With the described structure and similar structures and methods within the scope of the invention, numerous advantages are obtained. Deeper and quicker coagulation is possible.
  • the conductive solution infused onto and into the tissues maintains relatively consistent maximal electrical contact areas, substantially preventing hot spots and allowing higher power than soft coagulation. Little to no arcing, cutting smoke or char is formed. Jaw and tissue surface temperatures are lower than otherwise, resulting in significantly less adhesion of tissue to jaw surfaces, and substantially no desiccation.
  • One mode of coagulation may be used in the place of the three modes soft, forced, and spray. Coagulation is possible of even the most challenging oozing tissues such as lung, liver and spleen tissues.
  • Coagulation is more precise, where other coagulation modes sometimes spark to the sides and produce coagulation where not desired.
  • tissue sealing may occur alone, or be accompanied with mechanical cutting, as by a retractable and advancable blade as in U.S. Patent No. 5,458,598, and as with blade 1210 in Fig. 12, or otherwise.
  • the tissue sealing itself is understood to occur by flow of electrolytic solution to the manipulating portions of the forceps in combination with energization of the solution with electrical energy, and when included, in combination with pressure on, or compression of, the tissue.
  • Compression of tissue is understood to deform tissues into conditions of sealing of tissues and especially vascalature.
  • Compression of tissue followed by application of solution and energy is understood to permanently maintain compressed deformation of tissue, when present, and to shrink tissue and cause proteins to fix in place. Additional understanding of others is provided in the Yates et al. patent referenced above.
  • the body of the forceps itself may or not be energized.
  • the solution primarily provides the beneficial functions and effects of the instrument.
  • the effectiveness and extent of the tissue sealing is a function primarily of the type of tissue being manipulated, the quantity of electrolytic solution supplied to the tissue, and the power of the electrical energy supplied to the solution.
  • Tissues not previously considered to be suitable for manipulation, as by cutting are rendered suitable for manipulation by being sealed against flow of fluids, including bodily fluids and air.
  • lung tissue may be cut after sealing, with the tissue adjacent the sealed tissue retaining blood and air. Examples of the principal parameters of specific uses of the invention are provided in the following table. It is understood that the combined consequences of the parameters are that energy density in the tissue to be treated is in a range to effect sealing of the tissue. However, in general, a power output of 7 to 150 watts is preferred.
  • the electrolytic solution is saline.
  • the device in use was a device as in Fig. 2, with electrodes of 16 gauge tubing, 1 cm long.
  • the tool in use in the second and third examples was a forceps as in Fig. 6, with jaw portions 348, 350, to be described, 4 mm wide and 2.8 cm long. No desiccation was observed at the tissue/electrode interface.
  • the device of Fig. 2 is preferred for vessel closure.
  • a wide variety of the currently installed electrosurgical generators could and will provide proper waveforms and power levels for driving the described forceps.
  • the waveforms need only be sine waves at about 500 kHz, and the power need only be about 30 or more watts.
  • Valley lab generators are acceptable and widely available.
  • the electrolytic solution supplied to the forceps need only be saline, although a variety of non-toxic and toxic electrolytic solutions are possible.
  • Toxic fluids may be desirable when excising undesired tissues, to prevent seeding during excision.
  • Use of a pressure bulb is possible, as shown in Fig. 8.
  • a flexible reservoir such as an intravenous (IV) bag 410 is surrounded with a more rigid rubber bulb 412 that is pressurized with air through an attached squeeze bulb 414.
  • the reservoir is filled with solution through an injection port 416.
  • An outflow line 418 has a filter 420 and a capillary tube flow restrictor 422 to meter flow.
  • a clamp or valve 424 and connector 426 are also provided.
  • a typical flow rate is one to two (1-2) cc/min at a maximum pressure of approximately sixteen pounds per square inch (16 psi)(52 rnmHg).
  • An example of opening diameters, numbers, and flow rate is as follows: opening diameter, 0.16 mm; number of openings, 13 per cm; and flow rate, 2 cc's per minute. A long slit has also been used and found acceptable. In this embodiment, flow rates of 0.01 to 50 cc/min are preferred. It is understood that highly significant to the invention is the spacing of a plurality of solution openings along the jaw inner surfaces. Single openings as in
  • Ohta et al. that effectively pour fluid adjacent one portion of forceps, are generally not considered suitable or effective. Openings along outer surfaces of the jaws, opposite inner surfaces, are also generally not considered suitable or effective.
  • Figs. 4 and 5 the configurations of the most preferred solution openings are disclosed.
  • a jaw 240 longitudinally spaced openings 166 are rotated from those shown in Fig. 4, in a jaw portion 250, to turn the openings away from most direct contact with tissues, and more carefully eliminate any unintended plugging of the openings.
  • Electrical insulators 268 in the form of elongated strips extend alongside the tubes which include the openings 166.
  • open surgical forceps 330 include jaws 338, 340 with jaw portions 348, 350.
  • the jaw portions 348, 350 include spaced solution infusion openings 166 in the central longitudinal groove of a plurality of grooves 162.
  • the open surgical forceps 330 benefits from the unique enhancement of electrosurgical functions through the infusion of electrolytic solutions onto and into tissues through the spaced, laser drilled, solution infusion openings in the grooves 162.
  • open surgical devices 430 and 530 also include jaws 438, 440 and 538, 540, respectively.
  • the jaw portions of these devices are curved, and in the case of device 430, circular, to adapt the invention to specialized surgical situations of tissue manipulation, such as those in which fluid flow is to be terminated all around a tissue to be isolated and resected or excised.
  • An example of such a tissue is a lesion or tumor of lung tissue.
  • tissue In endoscopic or open surgery, such lesions or tumors may be encircled and/or isolated, surrounding tissue sealed, and the lesions or tumors thereafter resected.
  • a one centimeter margin is resected about any lesion or tumor, with the lesion or tumor.
  • the devices 430, 530 are formed of substantially square cross-section tubing, best shown in the cross-sectional drawing of Fig. 11.
  • the tubing incorporates a central, depressed, cross-sectionally rectangular, and elongated groove 462 and equilaterally spaced, cross-sectionally triangular, parallel, and elongated outer grooves 464, 465.
  • Laser drilled openings 466 similar to openings 166 described above, are located in and spaced along the central groove 462.
  • Alternate cross-sectional shapes of tubing may be employed, as exemplified in Fig. 12.
  • Flatter operative, e.g., inner faces of tubing are preferred within limits of constructing and arranging the operative faces to facilitate firm grasping and holding of tissue.
  • Non-operative surfaces being less of concern, may adapt to a variety of contours for a variety of alternate reasons.
  • malleable tubing may be employed, to permit the surgeon to shape the operative portions of the invented devices to specific physiological situations.
  • the infusion of conductive solutions, referred to here also as electrolytic solutions, simultaneously with the application of RF energy to tissues is discussed in further detail in U.S. Patent No.
  • the forceps may be varied in a range from excision and cutting biopsy forceps, to endoscopic forceps, dissecting forceps, and traumatic, atraumatic and flexible endoscopic grasping forceps.
  • the jaws may close into full and tight contact with each other, or close into spaced relationship to each other, to accommodate tissue for purposes other than cutting.
  • parallel spaced relationship is considered most preferably for uniformity of application of pressure across tissue to be affected.
  • Devices according to the invention may be constructed and arranged to grasp, hold, fix, cut, dissect, expose, remove, extract, retrieve, and otherwise manipulate and treat organs, tissues, tissue masses, and objects.
  • Endoscopic forceps according to the invention may be designed to be used through a trocar. Bipolar and monopolar currents may both be used. With monopolar current, grounding pads may be placed under patients. The described grooves may be eliminated in favor of alternative grooves.
  • the term Amanipulate® includes the described functions of grasping, holding, fixing, cutting, dissecting, exposing, removing, extracting, retrieving, coagulating, ablating and otherwise manipulating or similarly treating organs, tissues, tissue masses, and objects.
  • Atissue® includes organs, tissues, tissue masses, and objects.
  • Aelectrical energy sufficient to affect tissue® includes electrical energy sufficient to raise tissue temperature to cause non-reversible effect on tissue as described above.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plasma & Fusion (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)
EP98935803A 1997-07-18 1998-07-20 Elektrochirurgische vorrichtung Expired - Lifetime EP0996380B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89639897A 1997-07-18 1997-07-18
US896398 1997-07-18
PCT/US1998/014930 WO1999003414A1 (en) 1997-07-18 1998-07-20 Tissue sealing electrosurgery device and methods of sealing tissue

Publications (2)

Publication Number Publication Date
EP0996380A1 true EP0996380A1 (de) 2000-05-03
EP0996380B1 EP0996380B1 (de) 2005-01-05

Family

ID=25406140

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98935803A Expired - Lifetime EP0996380B1 (de) 1997-07-18 1998-07-20 Elektrochirurgische vorrichtung

Country Status (4)

Country Link
EP (1) EP0996380B1 (de)
AU (1) AU1645499A (de)
DE (1) DE69828506T2 (de)
WO (1) WO1999003414A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7789883B2 (en) 2007-02-14 2010-09-07 Olympus Medical Systems Corp. Curative treatment system, curative treatment device, and treatment method for living tissue using energy
US7935114B2 (en) 2007-02-14 2011-05-03 Olympus Medical Systems Corp. Curative treatment system, curative treatment device, and treatment method for living tissue using energy

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096037A (en) 1997-07-29 2000-08-01 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
US7364577B2 (en) 2002-02-11 2008-04-29 Sherwood Services Ag Vessel sealing system
US6524675B1 (en) 1999-05-13 2003-02-25 3M Innovative Properties Company Adhesive-back articles
US8048070B2 (en) 2000-03-06 2011-11-01 Salient Surgical Technologies, Inc. Fluid-assisted medical devices, systems and methods
US7811282B2 (en) 2000-03-06 2010-10-12 Salient Surgical Technologies, Inc. Fluid-assisted electrosurgical devices, electrosurgical unit with pump and methods of use thereof
US6488680B1 (en) * 2000-04-27 2002-12-03 Medtronic, Inc. Variable length electrodes for delivery of irrigated ablation
US6546935B2 (en) * 2000-04-27 2003-04-15 Atricure, Inc. Method for transmural ablation
US7799026B2 (en) 2002-11-14 2010-09-21 Covidien Ag Compressible jaw configuration with bipolar RF output electrodes for soft tissue fusion
US9848938B2 (en) 2003-11-13 2017-12-26 Covidien Ag Compressible jaw configuration with bipolar RF output electrodes for soft tissue fusion
US7367976B2 (en) 2003-11-17 2008-05-06 Sherwood Services Ag Bipolar forceps having monopolar extension
US7722607B2 (en) 2005-09-30 2010-05-25 Covidien Ag In-line vessel sealer and divider
CA2561034C (en) 2005-09-30 2014-12-09 Sherwood Services Ag Flexible endoscopic catheter with an end effector for coagulating and transfecting tissue
US8469957B2 (en) * 2008-10-07 2013-06-25 Covidien Lp Apparatus, system, and method for performing an electrosurgical procedure
US8016827B2 (en) 2008-10-09 2011-09-13 Tyco Healthcare Group Lp Apparatus, system, and method for performing an electrosurgical procedure
US8114122B2 (en) 2009-01-13 2012-02-14 Tyco Healthcare Group Lp Apparatus, system, and method for performing an electrosurgical procedure
US8187273B2 (en) 2009-05-07 2012-05-29 Tyco Healthcare Group Lp Apparatus, system, and method for performing an electrosurgical procedure
US8133254B2 (en) 2009-09-18 2012-03-13 Tyco Healthcare Group Lp In vivo attachable and detachable end effector assembly and laparoscopic surgical instrument and methods therefor
US8112871B2 (en) 2009-09-28 2012-02-14 Tyco Healthcare Group Lp Method for manufacturing electrosurgical seal plates
US8979838B2 (en) 2010-05-24 2015-03-17 Arthrocare Corporation Symmetric switching electrode method and related system
US9113940B2 (en) 2011-01-14 2015-08-25 Covidien Lp Trigger lockout and kickback mechanism for surgical instruments
US9844384B2 (en) 2011-07-11 2017-12-19 Covidien Lp Stand alone energy-based tissue clips
US20150324317A1 (en) 2014-05-07 2015-11-12 Covidien Lp Authentication and information system for reusable surgical instruments
US10213250B2 (en) 2015-11-05 2019-02-26 Covidien Lp Deployment and safety mechanisms for surgical instruments
US11844562B2 (en) 2020-03-23 2023-12-19 Covidien Lp Electrosurgical forceps for grasping, treating, and/or dividing tissue
DE102020207835A1 (de) 2020-06-24 2021-12-30 Robert Bosch Gesellschaft mit beschränkter Haftung Chirurgisches Instrument

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364394A (en) * 1989-12-21 1994-11-15 Mehl Thomas L Method of removing hair from the body and inhibiting future growth
US5300087A (en) * 1991-03-22 1994-04-05 Knoepfler Dennis J Multiple purpose forceps
US5395312A (en) 1991-10-18 1995-03-07 Desai; Ashvin Surgical tool
US5318589A (en) 1992-04-15 1994-06-07 Microsurge, Inc. Surgical instrument for endoscopic surgery
US5403312A (en) 1993-07-22 1995-04-04 Ethicon, Inc. Electrosurgical hemostatic device
US5431649A (en) 1993-08-27 1995-07-11 Medtronic, Inc. Method and apparatus for R-F ablation
US5458598A (en) 1993-12-02 1995-10-17 Cabot Technology Corporation Cutting and coagulating forceps
US5417709A (en) * 1994-04-12 1995-05-23 Symbiosis Corporation Endoscopic instrument with end effectors forming suction and/or irrigation lumens
GB9409625D0 (en) * 1994-05-13 1994-07-06 Univ London Surgical cutting tool
US5609151A (en) 1994-09-08 1997-03-11 Medtronic, Inc. Method for R-F ablation
AU6769096A (en) * 1995-08-07 1997-03-05 Cabot Technology Corporation Cutting and coagulating forceps

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9903414A1 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7789883B2 (en) 2007-02-14 2010-09-07 Olympus Medical Systems Corp. Curative treatment system, curative treatment device, and treatment method for living tissue using energy
US7935114B2 (en) 2007-02-14 2011-05-03 Olympus Medical Systems Corp. Curative treatment system, curative treatment device, and treatment method for living tissue using energy

Also Published As

Publication number Publication date
WO1999003414A1 (en) 1999-01-28
AU1645499A (en) 1999-02-10
DE69828506T2 (de) 2006-01-05
EP0996380B1 (de) 2005-01-05
DE69828506D1 (de) 2005-02-10

Similar Documents

Publication Publication Date Title
US6096037A (en) Tissue sealing electrosurgery device and methods of sealing tissue
EP0996380B1 (de) Elektrochirurgische vorrichtung
US7223267B2 (en) Ultrasonic probe with detachable slidable cauterization forceps
CA2816424C (en) System and method for electrosurgical conductive gas cutting for improving eschar, sealing vessels and tissues
US8475455B2 (en) Fluid-assisted electrosurgical scissors and methods
US7422588B2 (en) Pen-type electrosurgical instrument
JP4108928B2 (ja) 電気外科的組織除去のための装置
US20020133149A1 (en) Electrosurgical systems and methods for hair transplantation and epilation
JP2001523513A (ja) 皮膚の電気外科治療のシステム及び方法
Sajjadian et al. Electrosurgery in the head and neck
Munro et al. Energy-based surgical devices
BRILL et al. Energy-based surgical devices 3
Sinha Energy Sources in Surgical Practice
Watanabe et al. Monopolar electrocautery with spray coagulation in laparoscopic colectomy
Azziz Electrosurgery and Thermocoagulation at Operative Endoscopy
de Blok et al. HF Electrosurgery in Operative Gynecologic Endoscopy: General Aspects of Electrosurgery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT NL SE

17Q First examination report despatched

Effective date: 20030411

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61B 18/00 A

RTI1 Title (correction)

Free format text: ELECTROSURGERY DEVICE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MEDTRONIC INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MEDTRONIC, INC.

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB IT NL SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69828506

Country of ref document: DE

Date of ref document: 20050210

Kind code of ref document: P

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050720

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050720

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050721

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20051006

ET Fr: translation filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060201

EUG Se: european patent has lapsed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20050720

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20060201

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20170726

Year of fee payment: 20

Ref country code: DE

Payment date: 20170727

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69828506

Country of ref document: DE